Skip to main navigation Skip to search Skip to main content

Targeting KRAS G12C and G12S mutations in lung cancer: In silico drug repurposing and antiproliferative assessment on A549 cells

  • Mansour S. Alturki*
  • , Nada Tawfeeq*
  • , Amal Alissa
  • , Zahra Ahbail
  • , Mohamed S. Gomaa
  • , Abdulaziz H. Al Khzem
  • , Thankhoe A. Rants'o
  • , Mohammad J. Akbar
  • , Waleed S. Alharbi
  • , Bayan Y. Alshehri
  • , Amjad N. Alotaibi
  • , Fahad A. Almughem
  • , Abdullah A. Alshehri
    • *Corresponding author for this work
  • Imam Abdulrahman Bin Faisal University
  • University of Utah
  • King Abdulaziz University
  • King Abdulaziz City for Science and Technology

Research output: Contribution to journal › Article › peer-review

4   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Targeting KRAS G12C and G12S mutations in lung cancer: In silico drug repurposing and antiproliferative assessment on A549 cells'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science